Short Information | Exagen Inc. (NYSE:XGN)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 13,399 |
Total Actual Volume | 1,635,561 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 670 |
Average Short Percentage | 1.36% |
Is there a XGN Short Squeeze or Breakout about to happen?
See the XGN Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
02-12-2020 | $18.20 | $18.04 | $18.77 | $17.605 | 215,638 | 898 | 0.42% |
02-11-2020 | $18.09 | $18.13 | $19.97 | $17.69 | 30,889 | 649 | 2.1% |
02-10-2020 | $19.66 | $18.15 | $19.66 | $18.03 | 19,529 | 571 | 2.92% |
02-07-2020 | $19.97 | $19.77 | $20.15 | $19.09 | 61,542 | 110 | 0.18% |
02-06-2020 | $20.45 | $19.99 | $21.29 | $19.00 | 43,078 | 1,609 | 3.74% |
02-05-2020 | $20.45 | $20.71 | $21.53 | $19.80 | 50,094 | 286 | 0.57% |
02-04-2020 | $21.08 | $20.43 | $21.51 | $20.26 | 38,224 | 300 | 0.78% |
02-03-2020 | $20.81 | $21.04 | $21.48 | $20.485 | 48,747 | 15 | 0.03% |
01-31-2020 | $22.49 | $20.65 | $22.49 | $20.07 | 77,271 | 581 | 0.75% |
01-30-2020 | $22.64 | $22.50 | $23.48 | $21.46 | 109,649 | 1,492 | 1.36% |
01-29-2020 | $22.98 | $23.50 | $24.50 | $22.01 | 128,349 | 210 | 0.16% |
01-28-2020 | $24.07 | $22.955 | $24.40 | $22.5339 | 27,372 | 2,551 | 9.32% |
01-27-2020 | $21.69 | $23.82 | $24.98 | $20.105 | 104,890 | 1,605 | 1.53% |
01-24-2020 | $20.9543 | $22.10 | $22.18 | $20.83 | 88,730 | 103 | 0.12% |
01-23-2020 | $22.84 | $21.10 | $22.85 | $20.93 | 48,165 | 581 | 1.21% |
01-22-2020 | $22.83 | $22.59 | $23.20 | $22.09 | 52,884 | 393 | 0.74% |
01-21-2020 | $23.30 | $22.96 | $24.35 | $22.27 | 80,542 | 125 | 0.16% |
01-17-2020 | $24.43 | $23.50 | $24.47 | $22.64 | 93,888 | 642 | 0.68% |
01-16-2020 | $24.34 | $24.19 | $24.62 | $23.70 | 248,224 | 455 | 0.18% |
01-15-2020 | $24.28 | $24.03 | $25.41 | $23.71 | 67,856 | 223 | 0.33% |
News, Short Squeeze, Breakout and More Instantly...
CARLSBAD, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March 31, 2024. First Quarter Highlights: Recognized total revenue of $14.4 million in the ...
Aileron Therapeutics Inc. (ALRN) is expected to report for Q1 2024 DZS Inc. (DZSI) is expected to report $-0.09 for Q1 2024 Bitfarms Ltd. (BITF) is expected to report $-0.03 for Q1 2024 180 Degree Capital Corp. (TURN) is expected to report for quarter end 2024-03-31 Abacus Life In...
CARLSBAD, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results for the quarter ended March 31, 2024, before the market opens on Monday, May 13, 2024. John Aballi, Exagen’s President and Chief Executiv...